Obesity is a complex metabolic and public health concept defined by excessive body fat accumulation, studied across diverse academic fields to understand its multifactorial causes, physiological impacts, associated comorbidities, and significant global health burden.
Ontological type
Prevention and Management
Etiology
Pathophysiology
Neuroendocrine Energy Homeostasis
1940 - 1976
Adipose Endocrine Inflammation
1977 - 2003
Global Clinical Consolidation
2004 - 2024
Neuroendocrine Energy Homeostasis era
S. W. Ranson [1] was a key figure associated with Northwestern University [3] during the Neuroendocrine Energy Homeostasis era. In his 1940 study Hypothalamic lesions and adiposity in the rat [6], S. W. Ranson [1] demonstrated that hypothalamic damage alters adiposity in rats, and his 1942 paper on early hypophysectomy and hypothalamic obesity [7] highlighted endocrine control of adiposity, a cornerstone of neuroendocrine regulation in this era. Daniel Porte [2] was associated with the University of Washington [4] and Columbia University [5] during this era. His 1967 paper The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects [8] argued for the role of basal insulin in glucose homeostasis and insulin response assessment, shaping metabolic research and energy balance models in this era.
Adipose Endocrine Inflammation era
Richard F. Hamman[1] is associated with Johns Hopkins University[3] and The University of Texas Health Science Center at San Antonio[4] as a leading figure in adipose endocrine and inflammatory research during the Adipose Endocrine Inflammation era. His key contribution in this era centers on the 2002 paper Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin[7], which demonstrated that lifestyle modification or metformin can reduce diabetes incidence and thereby linked adiposity management to population-level cardiometabolic risk. William C. Knowler[2] is associated with University of California, San Francisco[5] and Stanford University[6] as a prominent contributor to adipose-driven metabolic research in this era. Knowler's work on the same 2002 study[7] helped translate mechanistic adipose inflammation insights into prevention strategies, underscoring how population trials can reshape risk models and clinical priorities.
Global Clinical Consolidation era
Katherine M. Flegal [1], affiliated with University of California, San Francisco [3] and Stanford University [4], emerged as a leading figure in obesity epidemiology during this era. Her key contributions include national prevalence assessments such as Prevalence of Overweight and Obesity in the United States, 1999-2004 [6], Prevalence of Childhood and Adult Obesity in the United States, 2011-2012 [7], and Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002 [8], which defined baseline epidemiology and informed surveillance and policy development in obesity care. Cynthia L. Ogden [2], affiliated with University of California, San Francisco [3] and University of Bristol [5], contributed to standardized obesity surveillance in this era. Her work on the same trio of prevalence papers [6][7][8] helped establish robust baseline data, track demographic and geographic patterns, and support guideline-driven, multisectoral approaches to obesity management.